Albion Financial Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Sell
21
-5
-19% -$2.8K ﹤0.01% 418
2026
Q1
$14.6K Buy
26
+5
+24% +$3.21K ﹤0.01% 372
2025
Q4
$14.2K Hold
21
﹤0.01% 369
2025
Q3
$13.4K Buy
+21
New +$12.7K ﹤0.01% 366
2025
Q1
Sell
-584
Closed -$241K 644
2024
Q4
$241K Buy
584
+3
+0.5% +$1.32K 0.02% 175
2024
Q3
$294K Sell
581
-11
-2% -$5.34K 0.02% 158
2024
Q2
$288K Sell
592
-20
-3% -$10K 0.02% 164
2024
Q1
$330K Buy
612
+21
+4% +$11.5K 0.03% 154
2023
Q4
$328K Sell
591
-8
-1% -$3.76K 0.03% 156
2023
Q3
$262K Buy
599
+44
+8% +$21.9K 0.02% 155
2023
Q2
$279K Sell
555
-60
-10% -$28.8K 0.02% 158
2023
Q1
$308K Sell
615
-55
-8% -$26.3K 0.03% 149
2022
Q4
$273K Sell
670
-368
-35% -$143K 0.03% 153
2022
Q3
$338K Buy
1,038
+60
+6% +$22K 0.03% 143
2022
Q2
$343K Sell
978
-262
-21% -$107K 0.03% 149
2022
Q1
$678K Buy
1,240
+54
+5% +$28.4K 0.06% 132
2021
Q4
$781K Sell
1,186
-1
-0.1% -$628 0.06% 128
2021
Q3
$738K Buy
+1,187
New +$798K 0.06% 131

Other funds holding IDXX

Albion Financial Group's IDXX Position: Q2 2026 in Review

Albion Financial Group reduced its Idexx Laboratories (IDXX) stake by 19% in Q2 2026, selling an estimated $2.8K and leaving 21 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #418.

Albion Financial Group first reported a position in IDXX in Q3 2021 and has held it in 18 quarters since. The position peaked at $781K in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Albion Financial Group held 21 shares of Idexx Laboratories worth $11.1K as of Q2 2026.
  • Albion Financial Group sold 5 Idexx Laboratories shares in Q2 2026, an estimated $2.8K.
  • Idexx Laboratories made up ﹤0.01% of Albion Financial Group's portfolio in Q2 2026, its #418 holding.
  • Albion Financial Group first reported a position in Idexx Laboratories in Q3 2021 and has held it in 18 quarters since.
  • Albion Financial Group's Idexx Laboratories position peaked at $781K in Q4 2021.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.